Dr Tina Fang

Individuals with weakened immune systems face an increased risk of developing skin cancer, particularly non-melanoma skin cancers (NMSC) like squamous cell carcinoma (SCC) and, to a lesser extent, basal cell carcinoma (BCC). This risk is especially pronounced in organ transplant recipients (OTRs), cancer patients on immunosuppressive therapy, and individuals with chronic immune conditions. Understanding why

Skin cancer treatment has undergone remarkable advancements in recent years, moving beyond traditional therapies like surgery and chemotherapy. With new innovations in immunotherapy, artificial intelligence (AI) diagnostics, gene therapy, and non-invasive treatments, the future of skin cancer care is becoming increasingly targeted and personalised. This article explores the latest breakthroughs in skin cancer treatment and

At ISO Skin Cancer Clinic, we understand the importance of evidence-based discussions when it comes to ultraviolet (UV) light and melanoma risk. While UV exposure is often cited as the primary environmental factor in melanoma development, some scientific arguments challenge its role as the sole cause. This article will explore both perspectives, examine the evidence

Outdoor workers spend significant time under the sun, making them one of the highest-risk groups for skin cancer. Unlike the general population, they are exposed to cumulative, long-term ultraviolet (UV) radiation, which significantly increases their risk of developing basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)​. This article explores why outdoor workers face a

Skin cancer is commonly associated with fair-skinned individuals, but it can affect people of all skin tones. While lighter skin types have a higher overall risk, those with darker skin tones often experience delayed diagnosis, leading to worse outcomes. At ISO Skin Cancer Clinic, we emphasise the importance of sun protection for everyone, regardless of